Purpose

Our Purpose

We use the power of antibodies to treat cancer and other serious diseases.
Scientist holds test tube sample, with another scientist helping to analyse findings in the lab.Scientist holds test tube sample, with another scientist helping to analyse findings in the lab.

Transforming lives

ÐǺ£ÆåÅÆ's purpose is to improve the lives of patients through innovative and differentiated antibody therapeutics.

ÐǺ£ÆåÅÆ representative sits with patient at a computer, both women are smiling.

Our vision

Our aspiration for the future is that by 2030, our knock-your-socks-off KYSO antibody medicines® are transforming the lives of people with cancer and other serious diseases.

“  
At ÐǺ£ÆåÅÆ, we strive to be innovative and forward-thinking in everything we do, not just in our approach to discovering and developing differentiated antibody therapeutics.

Deirdre P. Connelly

Board of Directors Chair


Unleashing innovation

A woman presents a slideshow titled “Our future†to her ÐǺ£ÆåÅÆ colleagues.
Our strategy
We have four strategic priorities that will help us achieve and deliver on our 2030 Vision.

  • Invest in our people and culture
  • Build a world-class differentiated pipeline
  • Bring our own medicines to patients
  • Become a leading integrated biotech innovation powerhouse
A group of ÐǺ£ÆåÅÆ colleagues sit and work collaboratively in a common workspace area.
Our values
ÐǺ£ÆåÅÆ's quest to turn science into medicine is guided by four core values:

  • Passion for innovation
  • Determination—being the best at what we do
  • Integrity—we do the right thing
  • We work as one team and respect each other
Two colleagues in have a friendly conversation in an open office plan environment.
Our achievements
We've come a long way since we were founded in Copenhagen, Denmark, in 1999:

  • Eight approved therapies incorporating ÐǺ£ÆåÅÆ innovation*
  • Four proprietary technologies
  • Multiple proprietary clinical programs
  • Robust pre-clinical pipeline
  • World-class leaders with antibody R&D and Commercialization expertise
  • Partner of choice
  • Solid financials
  • 2,500+ employees across five international locations

* Two therapies co-marketed by ÐǺ£ÆåÅÆ and partners, six out-licensed products marketed by partners.
Explore further
Two colleagues smile in conversation in the ÐǺ£ÆåÅÆ office gathering space.

Our Impact

A person riding their bike in front of an office building with large glass windows.

Sustainability & ESG

Two scientists work collaboratively in a modern laboratory environment.

Antibody Science